Hypertension Screening in Pregnancy: Remembering the Basics, Charting the Future

Affiliations

Editorial

Anna E Denoble et al. JAMA. 2023.

. 2023 Sep 19;330(11):1040-1041.

doi: 10.1001/jama.2023.15088.

¹ Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut.

No abstract available

Comment in

Screening for Hypertensive Disorders of Pregnancy in the US-A New Hypertensive Urgency.
Mitta S, Gross CP, Simon MA. Mitta S, et al. JAMA Intern Med. 2023 Nov 1;183(11):1185-1186. doi: 10.1001/jamainternmed.2023.4723. JAMA Intern Med. 2023. PMID: 37725383 No abstract available.

Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
US Preventive Services Task Force; Barry MJ, Nicholson WK, Silverstein M, Cabana MD, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Li L, Ogedegbe G, Rao G, Ruiz JM, Stevermer J, Tsevat J, Underwood SM, Wong JB. US Preventive Services Task Force, et al. JAMA. 2023 Sep 19;330(11):1074-1082. doi: 10.1001/jama.2023.16991. JAMA. 2023. PMID: 37721605
Screening for Hypertensive Disorders of Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Henderson JT, Webber EM, Thomas RG, Vesco KK. Henderson JT, et al. JAMA. 2023 Sep 19;330(11):1083-1091. doi: 10.1001/jama.2023.4934. JAMA. 2023. PMID: 37721606